Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07461272

Self-hangIng Patient and Hyperbaric Oxygen Therapy _ SIPHON Study

Self-hangIng Patient and Hyperbaric Oxygen Therapy - SIPHON Study / Place de l'Oxygénothérapie Hyperbare Dans la Prise en Charge Des Tentatives de Pendaison

Status
Not Yet Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
University Hospital, Lille · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

During an attempted hanging, patients present severe neurological distress that can lead to major neuropsychiatric sequelae. These sequelae are notably due to significant cerebral edema related to hanging. Hyperbaric Oxygen therapy is known to reduce cerebral edema and improve cerebral perfusion. The main objective of the study is to evaluate in patients who have attempted hanging without presenting cardio-respiratory arrest, the effect of one Hyperbaric Oxygen therapy session in addition to standard intensive care management on a potential reduction in short-term neurological sequelae. Patients will benefit from either standard management or standard management associated with one Hyperbaric Oxygen therapy session

Conditions

Interventions

TypeNameDescription
DRUGOXYGENE MEDICINAL LIQUIDE AIR PRODUCTS MEDICALIn addition to standard intensive care management, patients will receive a hyperbaric oxygen therapy session within eight hours of admission to intensive care (the hyperbaric oxygen therapy session lasts two hours and must be completed eight hours after the hanging attempt).

Timeline

Start date
2026-03-01
Primary completion
2028-09-01
Completion
2028-09-01
First posted
2026-03-10
Last updated
2026-03-10

Source: ClinicalTrials.gov record NCT07461272. Inclusion in this directory is not an endorsement.